Skip Navigation

Display Mode:

  • Choose Default Style
  • Choose High Contrast
CPMC Sutter Health
  • Home
  • Employment
  • About CPMC
  • Quality
  • Find a Doctor
  • Services
  • Health Information
  • For Health Professionals
  • Giving & Volunteering
  • Directions
Section TitleAdvanced Specialty Care
  • Neuroscience Institute
    • Neuro-oncology
      • For Patients
      • For Physicians
      • Brain Cancer Services
      • CPMCRI Research Trials
      • Contact Us
    Main content

    Procedure Profile - Neuroscience Institute - Craniotomy for Brain Tumor

    Neuro-oncology

    California Pacific Medical Center Neuroscience Institute’s neurosurgical specialists bring new and advanced surgical options to the physicians we serve and the patients they care for. Working collaboratively, our neurosciences experts provide comprehensive patient care using leading-edge technology for treating the most complex neurological diseases and conditions. Through this procedure profile, our physicians illustrate actual medical situations that provide you with a window into their practice of diagnosis, treatment and patient recovery.

    For patient referrals: 1-888-637-2762

    Our neuro-oncology specialists are at the forefront of treating patients with brain tumors, delivering treatment options and performing microsurgery for primary tumors such as gliomas and meningiomas; skull base tumors such as craniopharyngiomas; as well as, metastatic tumors and systemic cancer.

    Printer Friendly PDF of Procedure Profile - Neuroscience Institute - Craniotomy for Brain Tumor (197KB)

    What is a Craniotomy?

    Considered one of the most common surgeries today for treating brain tumors and other brain related conditions, a craniotomy is a small strategically placed window in the skull allowing neurosurgeons access to the brain for tumor removal and surgical repair.

    How is Craniotomy Done?

    Emphasizing safety and efficacy, preoperative MRI, CT or arteriogram imaging studies identify the most appropriate site for the craniotomy. The head is then clamped in place to eliminate any movement during surgery. The surgeon shaves and marks the scalp where the scalp flap will be cut to expose the skull bone.
    Several small-interconnected burr holes are drilled into the skull. A craniotomy is used to cut from one hole to the next creating a removable bone section. The section of the skull is removed forming a window into the brain thus allowing access to the tumor. The bone section is retained and replaced after surgery, held in place with titanium fixtures. The scalp muscle and skin are stitched over the replaced bone section.

    How does craniotomy allow brain tumor treatment?

    Through the craniotomy window, neurosurgeons access the tumor directly. The tumor is removed using microsurgical techniques, aided, as necessary, with frameless stereotaxic techniques to minimize injury to the surrounding brain and to localize a deep-lying tumor.
    Microsurgery provides a magnified view of the operating area making it easier for neurosurgeons to see and remove tumor tissues while sparing more healthy brain tissue, as a smaller clean margin area is necessary. Neurosurgeons use microscissors and microscapels to remove diseased tissue. Additional surgical devices, ultrasonic aspirators and lasers, are employed for maximal or complete tumor removal to ensure patient safety.

    Why perform a craniotomy vs. radiosurgery or gammaknife?

    Craniotomy allows direct brain access and is most appropriate for larger tumors, particularly large and bulky tumors that compress brain structures and cause neurological dysfunction. Radiosurgery and gammaknife are techniques used more often for specific smaller tumors known to be radiosensitive in which total removal of the tumor is not necessary.

    What are the Risks?

    The risks of craniotomy are small, but include infection, bleeding, added neurological deficits caused by tumor removal, and seizures.

    Procedure Risks
    • Infection

    • Bleeding

    • Added neurological deficits caused by tumor removal

    • Seizures

    Who is a Candidate for Craniotomy?

    Candidates include patients diagnosed with new or recurrence of a primary brain tumor or glioma. Most patients diagnosed with meningiomas and many with other types of skull-based neoplasms are all potential candidates for craniotomy.

    Back to top

    Case Study

    Metastatic Colon Cancer

    Overview
    45-year old man presented status-post colon carcinoma resection with metastates to the liver and lung. He had had an excellent response to systemic chemotherapy with liver and lung lesion control. However, he began to complain of headache and progressive right side body weakness. MRI brain imaging identified a single lesion in the left posterior frontal brain region causing significant local edema and mass effect.

    Treatment:
    After the initiation of intravenous dexamethasone to control regional vasogenic edema, the patient was taken to surgery where craniotomy allowed complete microsurgical resection of the identified lesion. The pathology report confirmed metastatic colon carcinoma. Following surgery the patient’s headaches and neurological deficits quickly resolved. Focal radiation therapy was subsequently provided to this area to control any microscopic cellular residual of the tumor.

    Outcome
    At delayed follow-up this patient remained free of both systemic and intracranial disease for a period of over one year and later had recurrence of tumor in the liver and lymph nodes treated with additional chemotherapy.

    Patient Referral for Craniotomy

    Most patients require referral from their primary care provider or physician specialist prior to craniotomy procedure scheduling. However, depending on insurance benefits, patients can self-refer for neurosurgical evaluation.

    Insurance Coverage

    Medicare, Medi-Cal, and most private insurance plans cover craniotomy. In order to avoid unexpected medical expenses, it is always best for patients to contact their insurance company after their initial consultation and prior to treatment to confirm coverage for this service and obtain prior authorization.

    Back to top

    For more information

    For more information on craniotomy or the California Pacific Medical Center Neuroscience Institute’s Neuro-oncology services please contact:

    Brian Andrews, M.D., FACS
    Neuro-oncologist, Neurosurgeon
    Vice-chair, Department of Neuroscience


    Charles Cobbs, M.D.
    Neuro-oncologist, Neurosurgeon
    California Pacific Medical Center Research Institute
    Clinical Researcher, Primary Brain Tumors


    415-600-7760 phone
    415-600-7765 fax

    For patient referrals or more information on the California Pacific Medical Center Neuroscience Institute, please call 1-888-637-2762.

    About the Neuroscience Institute

    California Pacific Medical Center’s Neurosciences Institute provides compassionate patient care you can trust. Supported by leading-edge technology and state-of-the-art surgical techniques, as well as, clinical research, our comprehensive continuum of care offers patients with neurological conditions the best possible outcomes.

    Neurosurgery services are available at:
    California Pacific Medical Center
    Pacific Campus
    2333 Buchanan Street
    San Francisco, California 94115

    Davies Campus
    Duboce & Castro Streets
    San Francisco, California 94114

    Patient referrals 1-888-432-2762

    Back to top


























    MRI image of left-sided brain lesions


    MRI image of left-sided brain lesions



















































    MRI image of left-sided metastic brain lesion
    • About Our Sutter Health Network
    • Contact CPMC
    • Privacy Policy
    • Accessibility
    • Site Map

    © 2011 California Pacific Medical Center. All rights reserved. Sutter Health is a registered trademark of Sutter Health®, Reg. U.S. Patent. & Trademark office. CPMC serves patients from San Francisco, Marin, San Mateo, Oakland, Berkeley, Palo Alto, Santa Rosa, San Jose and the Bay Area.